Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a consent form agreeing to take part in the study.
- You are a man or woman between 18 and 75 years old.
- You have been diagnosed with advanced pancreatic cancer (confirmed by a tissue or cell sample) that has stopped responding to, or could not be tolerated with, standard treatments.
- You have at least one tumor that can be measured on scans and is large enough (over 1.5 cm) to be injected directly or through a special imaging-guided procedure called endoscopic ultrasound.
- You are generally well enough to carry out light activity and care for yourself (a doctor will assess this using a standard scale).
- Your blood counts, liver, kidney, and clotting function are within acceptable ranges based on recent blood tests (the trial team will check these for you).
- If you are a woman who could become pregnant, you must have a negative pregnancy test before joining, and both you and your male partner (if applicable) must agree to use reliable contraception during the study and for 3 months after the last dose; male participants must also agree not to donate sperm during this time.
Who may not be able to join:
- You have received certain cancer treatments recently, such as chemotherapy, immunotherapy, or targeted therapy within the past 2 to 6 weeks (depending on the type), traditional Chinese herbal medicine used as a cancer treatment within 2 weeks, radiotherapy within 2 weeks, or have previously received oncolytic virus treatment.
- You still have significant side effects from previous cancer treatments that have not fully resolved.
- You have cancer that has spread to your brain or the lining around your brain and is not under control.
- You have a known or suspected active autoimmune disease, such as lupus, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, or similar conditions.
- You have had a serious heart or stroke event in the past 12 months, have certain abnormal heart rhythms, have significant heart failure, or have blood pressure that cannot be controlled with treatment.
- You have an active, uncontrolled infection that requires treatment with antibiotics, antifungals, or antiviral medicines (including active tuberculosis or blood infections).
- You have HIV, active syphilis, active hepatitis C, or active hepatitis B with a high level of virus in your blood.
- You have used immune-boosting or immune-modifying medicines (such as interferon or interleukin) within the past 2 weeks.
- You are currently pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaofeng Zhang, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Phone: +86 18758245778
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Anti-tumor activity of hV01: overall response rate (ORR).; Anti-tumor activity of hV01: disease control rate (DCR).; Anti-tumor activity of hV01: duration of response (DOR).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.